SF General Hospital Foundation and O.A.S.I.S. Clinic Among the 16 Non-profits Across the Country to Receive Funding
Two Bay Area-based organizations, the San Francisco General Hospital Foundation and the O.A.S.I.S. Clinic, were awarded significant funding last week from Vertex Pharmaceuticals as part of a larger national initiative called Hep C Circle of Care.
The program is a pilot program developed to increase education, prevention and treatment options for communities that are vulnerable to Hepatitis C. The money will assist the organizations to diagnose, treat and cure those suffering from Hepatitis C.
The San Francisco General Hospital Foundation/Positive Health Program at SFGH will receive up to $250,000 to develop a primary-care program that increases Hepatitis C education, evaluation and treatment for vulnerable communities in San Francisco.
The Oakland-based O.A.S.I.S. Clinic (Organization to Achieve Solutions in Substance-Abuse) will receive up to $50,000 to pay for Hepatitis C toolkits that will provide information on prevention measures and available drug treatment programs to people in the Bay Area.
Nearly 4 million people in the United States and 12,000 people in San Francisco have Hepatitis C, yet 75 percent of them are unaware that they are infected. This high prevalence rate of infection presents significant medical, social and economic consequences and particularly can lead to liver disease. Programs like the two selected from the Bay Area will aim to address these issues and positively impact the future of hepatitis C management.
Vertex started the program to help support organizations, big and small, that are developing innovative ways to overcome various barriers that exist in the prevention of Hepatitis C. Last May, the FDA approved the company’s new Hepatitis C treatment, Incivek, which is shown to nearly double cure rates for most people who suffer from the disease. Read more here.
The introduction of new drugs, like Incivek, and a new found focus from the federal government spell good news from the millions of people afflicted by Hepatitis C in America.